- Filed
- May 6, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Apr 30, 2024 | 133.18M sh |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $285.34M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $272.52M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $1.36B |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $1.38B |
| Total Assets | Q1 2024 · Mar 31, 2024 | $1.95B |
| Total Assets | Q1 2024 · Dec 31, 2023 | $1.93B |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 158.77M sh |
| Stock Repurchased | Q1 2024 · Mar 31, 2023 | $42.56M |
| Capex | Q1 2024 · Mar 31, 2023 | $10.26M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | $45.29M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $672.53M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $664.86M |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | $0.27 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | $0.27 |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $45.13M |
| Net Income | Q1 2024 · Mar 31, 2023 | $42.72M |
| Operating Income | Q1 2024 · Mar 31, 2023 | $76.97M |
| Revenue | Q1 2024 · Mar 31, 2023 | $273.8M |